Autopsy report · NCT01337349

Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)

“Did not enroll”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Henry Ford Health System

Sponsor type

University, hospital or other

Conditions

Congestive Heart Failure

Interventions

Placebo; Pentoxifylline

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Hearing Resources and Outcomes in the Emergency Department (HERO-ED)
  “Did not meet enrollment” (83% match in meaning)
• Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds
  “unable to enroll” (83% match in meaning)
• Surgical PA-LAA Shunting: a Feasibility Study
  “Failure to enroll” (82% match in meaning)
• Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
  “did not enroll a patient” (80% match in meaning)
• Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder
  “patient did not enroll” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.